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The effect of Pbz+ on glutamate receptor activity in rat hippocampal neurons was investigated with a view of explaining the cognitive and learning 
deficits produced by this heavy metal. Pbz+ (2.5-50 PM) selectively inhibited N-methyl-D-aspartate (NMDA)-induced whole-cell and single-channel 
currents in a concentration-dependent but voltage-independent manner, without significantly altering currents induced by either quisqualate or 
kainate. The frequency of NMDA-induced channel activation was decreased by Pb 2+. Neither glycine (l&100 PM), nor Ca*+ (10 mM) reversed 
the effect of Pbz+. Pbz+ also inhibited the PH]MK-801 binding to rat hippocampal membranes in vitro. The elucidation of the actions of Pl?+ 
on the NMDA receptor ion channel complex provides important insights into the clinical and toxic effects of this cation. 
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1. INTRODUCTION 
The heavy metal Pb2+ is an environmental toxicant 
that poses a great threat to infant and child develop- 
ment, chiefly by causing a marked deficit in cognitive 
development [l-3]. Animal studies have indicated an 
impairment of the learning process after Pb2+ exposure 
[4-61. Hippocampal damage has been linked to deficits 
in reversal learning in rats and in monkeys [7,8], and 
exposure of young monkeys to Pb2+ produced similar 
learning disorders [9]. Our current understanding of 
synaptic plasticity suggests that long-term potentiation 
(LTP) may underlie the processes of learning and 
memory [IO-131 and several reports indicate that the 
NMDA subtype of glutamate receptors are involved in 
the process of LTP [14-161. In view of these observa- 
tions, we decided to examine the effect of Pb2+ on the 
glutamate receptor ion channel activity in cultured rat 
hippocampal neurons. The present study demonstrates 
that Pb2+ blocks the NMDA receptors located at 
glutamate synapses of rat hippocampal pyramidal 
neurons at concentrations which are capable of induc- 
ing neuropsychological disorders. A preliminary ac- 
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count of a part of this work has appeared in abstract 
form [17]. 
2. MATERIALS AND METHODS 
2.1. Tissue culture 
Hippocampi of fetuses obtained from 16-18-day pregnant rats 
(Sprague-Dawley) were dissociated and plated according to the 
methods described by Lima-Landman and Albuquerque [18]. For 
recording channel currents, 7-21-day old cultures were used. 
2.2. Patch-clamp technique 
The recordings of both whole-cell and single-channel currents were 
made according to standard patch-clamp techniques [19] using an 
LM-EPC 7 patch-clamp system (List Electronic, FRG). The external 
solution had the following composition (mM): NaCl 165, KC1 5, 
CaC12 2 (unless otherwise stated), Hepes 5, D-glucose 10, pH 7.3, 
340 mOsm plus TTX (0.3 /cM). The internal solution was composed 
of (mM): CsCl 80, CsF 80, CsEGTA 10, Hepes 10, pH 7.3, 
330 mOsm. The patch microelectrodes were pulled from borosilicate 
capillary glass (World Precision Instruments, New Haven, CT). The 
microelectrodes when filled with the internal solution had resistances 
of l-2 MO and 4-7 MD for whole-cell and single-channel ex- 
periments, respectively. No series-resistance ompensation was used 
in the present experiments. The data were stored on FM tape (Racal 
4DS) and filtered at 3 kHz. Whole-cell currents were analyzed using 
the PCLAMP program whereas analysis of single-channel currents 
were done using the IPROC-2 program. 
Whole-cell currents were induced by fast applications of the 
agonists either alone or in combination with the indicated concentra- 
tions of Pb2+ (Cl- salt). For rapid solution changes (about 100 ms), 
the outflow port of a U-shaped tube [20,21] was positioned near the 
cells (approximately 50 pm). We modified this system in order to ob- 
tain different outputs from the same port without moving the U-tube. 
The dead space for solution exchange was about 0.1 ml and the per- 
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fusion rate was about 0.1 ml/mitt. Short pulses (1 s) of agonist ap- 
plied to the cell surface gave reproducible and consistent responses 
under these conditions. These neurons were superfused at a rate of 
l-2 ml/min with external solution. 
Single-channel recordings were done in the outside-out patch con- 
figuration. NMDA and PbC12 were added into the static bath and 
mixed thoroughly to achieve equilibrium conditions before making 
the recordings. The addition of the drugs was restricted to pl volumes 
so that any dilution that might occur was kept to a minimum (< 5 % 
in the present experiments). All experiments were performed at room 
temperature (20-22°C). 
For the whole-cell experiments, the current amplitudes were 
measured and compared under different conditions. During the 
single-channel experiments, the channel open time, burst time and 
closed time and channel open probability were measured. A channel 
opening was detected when the current reached 50% of the estimated 
single-channel amplitude, and the closing when the current returned 
to the 50% level. To help eliminate noise points from analysis, it was 
further stipulated that the mean amplitude during a burst must be at 
least 80% of the estimated single-channel amplitude to be considered 
a valid event. For the purpose of counting the number of total open- 
ings and the total opening probability, the data were analyzed with 
a brief burst terminator (0.08 ms). Correction for the multiple level 
of openings was done arbitrarily by doubling the number of such 
multiples and adding it to the singles. The open probability was 
calculated by fitting the sampled points of the open state in the total 
amplitude histogram either to single or double Gaussian fits of the 
distribution. The area obtained from the above fits was converted to 
the total open duration in seconds by multiplying them by the sampl- 
ing interval (0.08 ms). Given the total recording time of that patch, 
the total open probability of all the channels under the patch could 
thus be calculated. The values obtained by this method were com- 
parable to those estimated by the frequency of individual openings 
even though it did not take into consideration the settings defined for 
detection of the open events. 
2.3. Binding studies 
Adult male Wistar rats were killed by decapitation, and the hip- 
pocampus was isolated and homogenized in 50 vols of cold Tris-HCI 
buffer (5 mM, pH 7.4). The homogenate was centrifuged at 17000 x 
g for 15 min. The pellet was suspended at a concentration of 1 mg 
protein/ml and used without further treatment. (+)-[‘H]MK-801 
(( +)-5-methyl-lO,l I-dihydro-5H-dibenzo[u,&cycle-hepten-5,10-im- 
ine maleate; 30 Ci/mmol; DuPont-NEN) was used as a probe for the 
ion channel of the NMDA receptor complex [22,23]. Binding was 
measured by a filtration procedure. Membranes (100 fig protein) were 
incubated in a medium containing 5 mM Tris-HCI, pH 7.4, 
[‘HIMK-801 (1 nM, unless otherwise indicated), and any competing 
ligands as required by the experiment. Nonspecific binding was deter- 
mined by including 10 PM unlabelled MK-801 in a parallel series of 
tubes. After a l-h incubation at room temperature, the suspension 
was filtered through glass fiber filters (no.32; Schleicher & Schuell, 
Keene, NH) using a Brandel (Gaithersburg, MD) filtration manifold. 
The filters were washed twice with cold buffer and their radioactivity 
content determined by liquid scintillation counting. Assays were 
routinely carried out in the absence and presence of 1OOpM 
glutamate, which stimulated specific binding by 40-70%; nonspecific 
binding was not affected by glutamate. 
3. RESULTS AND DISCUSSION 
To determine the nature of interaction of Pb2+ with 
the glutamate receptor, whole-cell currents evoked by 
NMDA, quisqualate or kainate were recorded from 
hippocampal neurons. When administered as an ad- 
mixture with NMDA, Pb2+ depressed the peak 
amplitude of the NMDA-activated whole-cell currents 
in a concentration-dependent manner (fig.1, table 1). 
The ICSO of Pb2+ for peak depression of NMDA cur- 
rents was about 10pM (n = 15). The effect of Pb2+ on 
the NMDA receptor was detected at concentrations as 
low as 2.5 PM, and almost complete abolition of the 
responses was observed at 50 PM. The inhibitory effect 
of Pb2+ was seen at both hyperpolarized and depolariz- 
ed membrane potentials, and a partial recovery of these 
responses occurred in about 5 min with nearly complete 
recovery in 20 min (fig. 1, table 1). The amplitude of the 
currents elicited by either quisqualate or kainate was 
slightly reduced at 50pM of Pb2+. Higher concentra- 
tions of Pb2+ (250pM) produced about 30% depres- 
sion of the currents (n = 6) induced by both quisqualate 
and kainate (fig. 1). Thus, Pb2+ appears to have a selec- 
tive blocking action at the NMDA-type of glutamate 
receptor. Earlier studies using the endplates from frog 
and mammalian muscles, also indicated a very weak in- 
hibitory action of Pb2+ occurring only at high concen- 
trations of this ion (100-200 ,uM) at the postsynaptic 
nicotinic acetylcholine receptors [24,25]. 
NMDA 
-50 mV 
QUISQUALATE * 
CONTROL Pb” 250 pM 
I 
-50 mV 
Y 
I 
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MNTROL Pbh 250 PM 
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Fig. 1. Effect of PbClr on whole-cell currents evoked by 50 FM each 
of NMDA, quisqualate and kainate from rat hippocampal neurons. 
Both inward and outward currents evoked by NMDA under control 
condition, in the presence of graded concentrations of PbClr, and 
5 min after wash, were obtained from the same neuron. Quisqualate 
and kainate responses were each obtained from separate neurons in 
the presence of 1 mM Mg’+ and 50 PM APV. 
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Table 1 
Effect of different concentrations of PbC12 on the whole-cell currents 
evoked by NMDA from rat hippocampal neurons 
Drug 
50 pM NMDA 
50gM NMDA + 1 ,uM Pb’+ 
50 PM NMDA + 5 ,uM Pb2+ 
50pM NMDA + lO@M Pb2+ 
50pM NMDA + 25 pM Pb2+ 
50pM NMDA + 50pM Pb2+ 
Wash (after 5 min) 
Wash (after 20 min) 
% of control response 
-50 mV +50 mV 
100 (15) 100 (9) 
101.5 * 1.5 (3) _ 
84.8 + 2.7 (6)* 81.4 + 5.3 (6) 
45.5 f 2.4 (15) 46.4 + 2.6 (9) 
30.1 + 2.0 (6) 22.7 t 2.1 (6) 
9.6 + 1.0 (15) 10.1 + 0.6 (9) 
47.7 + 3.7 (12) 42.9 + 2.5 (9) 
105.0 + 2.8 (3) - 
Values presented are mean + SE percentage of the control responses. 
The number of observations (n) obtained from a total of 15 neurons 
are indicated in parentheses after each value. * P < 0.01 
To understand the molecular mechanism of action of 
Pb2+ at the NMDA-activated channels, single channel 
recordings under outside-out patch-clamp conditions 
were made from hippocampal neurons. These studies 
indicated a marked reduction in the frequency of 
NMDA-activated channel openings (fig.2). The in- 
hibitory effect could be detected at Pb2+ concentrations 
as low as 500 nM. Quantitative analysis of the effect of 
Pb2+ performed at a concentration range between 5 
and 20 ,uM indicated a statistically significant reduction 
in the frequency of activation of NMDA channels 
(table 2). Frequency of activation was estimated either 
by counting the rate of individual openings or by ob- 
taining the total open probability, and both methods 
Table 2 
Effect of different concentrations of PbC12 on the frequency of 
activation of NMDA-evoked currents obtained from single channel 
recordings 
Group Percent of initial 10 min recording 
1 l-20 min 21-30 min 3 l-40 min 
5/4M 10,uM 20 yM 
Open frequency 
Control 110+ 5 111 f 19.6 75 t 14.6 
Pb2+ 64 + 10.7 27 t 3.7 14 * 3.6 
Open probability 
Control 105 + 11 100 + 15.5 79 * 13.5 
Pb2+ 57 * 10.5 20 + 3.9 11 * 1.7 
Responses are presented as percent of the initial value obtained 
during the first 10 min recording in each patch. Values are the 
mean + SE of either the frequency of individual openings or the total 
open probability obtained from 5 patches in each group. In the 
control group, patches were exposed to 10rM NMDA throughout 
the recording session, whereas in the Pb2+ group, the patches were 
exposed to NMDA first then to increasing concentrations of PbCh at 
the end of 10 min of recording, while maintaining the same 
concentration (10,~M) of NMDA. In both methods of analysis 
significant reduction (P < 0.05) (Student’s t-test) is seen in the Pbzf 
group 
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gave very similar results (table 2). The inhibitory effect 
of Pb2+ appeared within seconds after its addition, and 
the NMDA responses remained inhibited as long as 
Pb2+ was present. Unlike the quick onset of action, the 
reversal of Pb2+-induced inhibition measured under 
single-channel recording conditions, was much slower. 
On repeated washing of the outside-out patches for 
more than 30 min, only a partial recovery (30-40%) n = 
5 patches) of the responses was achieved. These results 
indicate that the action of Pb2+ at the NMDA-type 
glutamate channels is slowly reversible. The delay in the 
recovery time of Pb2+‘s action could have significance 
in that chronic exposure to the heavy metal, as occurs 
in vivo, can have a long-lasting effect at the NMDA 
receptors. Neuropsychological deficits have been 
reported in children [26] whose blood Pb2+ concentra- 
tion was in the range of 1.5-2.5 ,uM (30-50 rg/dl). 
Selective accumulation of Pb2+ in the rat hippocampus, 
compared to blood or other brain regions [27-291, im- 
plies that concentrations of Pb2+ in the analogous 
regions in children, could reach levels high enough to 
inactivate the NMDA receptors. Indeed, increased 
Pb2+ concentrations have been reported in the hip- 
pocampi of Pb2+-poisoned children [30]. 
To further examine the kinetic interaction of Pb2+ 
with the NMDA-type channels, the effects of this ca- 
tion were studied under a wide range of membrane 
potentials on the predominant, high conductance 
(40-45 pS in our study) channels using low concentra- 
tions of NMDA (5-10 FM). The time constants of open 
time, burst time and closed times analyzed in the 
absence and presence of Pb2+ are shown in fig.3. The 
closed time distribution disclosed a very fast (C 100 as), 
an intermediate (0.15-l .5 ms) and a long (10-1000 ms) 
exponential component. Both open and burst time 
histograms howed short and long components. In this 
study the long component of the open and burst times 
was analyzed because this component remained consis- 
tent in several patches studied. Under control condi- 
tions, the plot of the mean burst time vs membrane 
potential was linear. The value for burst time ranged 
from 9.5 to 13 ms over the range of potentials 
evaluated (-80 to +60 mV) (fig.3B), indicating very 
little voltage dependency. This is consistent with results 
of a previous report [3 l] for NMDA-activated channels 
from mouse central neurons. However, in contrast to 
their results [31], the channel open times decreased 
sharply with membrane hyperpolarization in a 
nonlinear manner (fig.3A). In addition, the in- 
termediate closed time increased exponentially with 
hyperpolarization (fig.3C) and the number of events 
per burst also increased at negative potentials under our 
control conditions (fig.3G). This effect resembles the 
blocking action of Mg2+ at NMDA-type channels [32] 
or bispyridinium compound-induced block at the 
nicotinic receptor channels [33,34] in contrast to that 
reported for the large-conductance glutamate receptor 
Volume 261, number 1 ~BSLETTERS February 1990 
ion channels in rat cerebellar granule neurons [351. Alternatively, some other unidentified blocking 
Even though Mg’+ was not added to our extracellular molecule may be responsible for the behavior of the 
medium in experiments where NMDA was used as the channel kinetics observed under our control conditions 
agonist, a small cont~ination of about l-3 PM of or the observed charmel kinetics may represent he in- 
Mg2+ could have originated from other salts used. trinsic gating mechanism of the NMDA channels. In 
NMDA 10 PM +50 mV NMDA + Ph’+ 10 pM 
-80 mV “4k 
-u -’ - V’ 
- -. -’ _c~’ 
- r -’ 
- 
cr 
-- 
d - 
- 
Fig.%. Samples of single channel recordings obtained from an outside-out patch from a rat hippocampal neuron. Channel currents activated by 
NMDA alone (left panels) and NMDA in the presence of 10 FM PbClz (right panels) are shown on a continuous time scale in each panel. Note 
the reduction in the frequency of openings as the predominant effect of Pb*’ seen at both positive and negative membrane potentials. Data shown 
were filtered at 2.5 kHz. 
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contrast to Mg2” [32], Pb2+ did not induce flickering of 
the channels during the open state nor change the mean 
channel open time over a potential range between -80 
and +50 mV (fig.3A). Further, Pb2+ had no effect on 
the intermediate closed time even though the long clos- 
ed interval was greatly prolonged. At the concentra- 
tions studied (up to 40pM), Pb”’ failed to alter the 
single channel conductance. At negative membrane 
potentials (-60 mV and more negative potentials), 
Pb2+ reduced the number of openings per burst and 
also reduced the burst duration. However, the most 
10 
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striking effect of Pb2+ was seen in the form of a reduc- 
tion in the channel activation which occurred at both 
hyperpolarized and depolarized membrane potentials. 
There was a reduction in the frequency of individual 
openings (fig.3E) and bursts (fig,3F), and a reduction 
in the overall probability of openings (fig.3H). 
Evidence for a competitive interaction between Pb2+ 
and Ca2+ has been demonstrated in studies on synaptic 
transmission in bullfrog sympathetic ganglion [36] and 
rat muscles [25,37], and on synaptosomal uptake of 
choline [38]. To test such an interaction between Pb2+ 
30. 
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Fig.3. Effect of PbClz on the kinetics of the single channel currents evoked by NMDA (10 PM) from hippocampal neuron. Relationship between 
membrane potential and mean channel open time (A), mean channel burst time (B), mean channel intermediate closed time (C), single channel 
current (D), frequency of open events (E), frequency of burst events (F), events per burst (G), probability of opening (H), were obtained in the 
absence (open circles) and presence of 10 pM PbClz (filled circles) from a single outside-out patch. Similar results were seen in 4 separate patches. 
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Fig.4. (A) Effect of PbCls on [‘H]MK-801 binding to the ion channel 
of the NMDA receptor complex. Binding was measured in the 
absence (open circles) or presence (filled circles) of 100 gM 
glutamate. Binding is expressed as fraction of the total specific 
binding measured in the absence of Pb’+; total specific binding was 
45% greater in the presence of glutamate. Each point represents the 
mean of 3 determinations. (B) Effect of MgClr on [3H]MK-801 
binding to the ion channel of the NMDA receptor complex. Binding 
was measured in the absence (open circles) or presence (closed circles) 
of 1OOpM glutamate. Binding is expressed as fraction of total 
specific binding measured in the absence of Mg’+. Each point 
represents the mean of 3 determinations. 
and Ca*+, we raised the extracellular concentration of 
Ca*+ from 2 mM to either 4 or 10 mM after eliciting 
the blocking action of Pb*+. Although a reduction in 
the single channel conductance and a transient increase 
in the frequency was observed, the inhibitory action of 
Pb*+ was maintained. Additionally, prior addition or 
removal of Ca*+, did not prevent or enhance respec- 
tively, the blocking action of Pb*+ on the NMDA 
receptor, suggesting that the effect of this metal ion was 
not mediated by a competitive interaction with Ca*+ at 
the NMDA channels. Raising the concentration of 
NMDA 2-lo-fold (5 patches) failed to antagonize the 
action of Pb*+ on the frequency of activation, in- 
dicating that Pb*+ did not compete for the agonist bin- 
ding site as in the case with 2-amino-5-phosphono 
valerate (APV) [39]. These results also rule out the 
possibility that the reduction in the frequency is not a 
consequence of a lowered NMDA concentration due to 
complex formation between the cation and the amino 
acid [32]. A Mg*+-like channel-blocking effect [32] is 
also unlikely because neither a voltage-dependent block 
nor the presence of flickering and open time reduction 
was observed in the presence of Pb*+. Addition of 
glycine (lo-100 PM) in the extracellular medium after 
eliciting Pb*+ -induced block, failed to antagonize the 
inhibitory effect of Pb*+ (observed in 6 patches), sug- 
gesting that the glycine site [40] is not involved in the 
action of Pb*+. 
MK-801 has been reported to be a potent and selec- 
tive noncompetitive blocker of the NMDA channels 
[22,41]. Access of [3H]MK-801 to its binding site inside 
the channel is controlled by drugs that act at the 
NMDA receptor and modify the opening of the channel 
[42]. The divalent cations Zn*+ and Mg*+ have been 
reported to affect the binding kinetics of [3H]MK-801 
to putative NMDA-type channels in brain membranes 
[42,43]. In the present study, we have examined the ef- 
fect of Pb*+ on the binding of [3H]MK-801 to the rat 
brain hippocampal membranes and compared its effect 
with that of Mg*+. As depicted in fig.4, Pb*+ inhibited 
the binding of [3H]MK-801 in a concentration- 
dependent manner with an I&O value close to 7 PM, 
and this effect was unaltered by inclusion of the 
agonist, glutamate, to the medium. Mg*+ was found to 
poorly inhibit the binding of [3H]MK-801 (IC50 = 
700 PM), but its inhibition was significantly enhanced 
in the presence of glutamate (IGO = 40,~M). These 
results are consistent with the notion that Mg*+ in- 
teracts with the open state of the NMDA channels 
[32,42]. The failure of glutamate to shift the inhibitory 
concentration-response curve of Pb*+ (fig.4) indicates 
that Pb*+ acts predominantly at a closed conformation 
of the NMDA receptor which is consistent with a lack 
of effect of Pb*+ on the mean channel open time of 
NMDA-induced single-channel currents. In addition, 
the effect of Pb*+ resembles that of Zn*+ in that both 
cations produce a voltage-independent block of the 
NMDA channels [44] and they exhibit similar blocking 
potencies (Pb*+ being more potent than Zn*+). Among 
several divalent cations, Zn*+ was found to be the most 
potent in inhibiting the binding of [3H]MK-801 [43]. 
Our study reveals that Pb*+ is even more potent than 
Zn*+ in this action. It appears from these findings that 
Pb*+ and Zn*+ may bind to a similar site in the NMDA- 
receptor channel complex. 
In summary, the present results demonstrate for the 
first time a blocking effect of Pb*+ on the NMDA sub- 
type of glutamate receptors. The concentrations at 
which the blockade occurs are comparable to that 
found in lead-poisoned children. Ample evidence in the 
literature is now available to indicate the key role of 
NMDA receptors in the processes of learning and 
memory and also the impairment of such processes by 
Pb*+. Therefore the blocking action of Pb*+ on the 
NMDA receptor ion channel certainly is an important 
clue for the exploration of the clinical effects of this 
cation. 
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